Sign up
Log in
Why Apple Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Share
Listen to the news

Shares of Apple Inc. (NASDAQ:AAPL) rose in pre-market trading as the company posted stronger-than-expected third-quarter results.

The iPhone maker reported fiscal third-quarter revenue of $94 billion, beating analyst estimates of $89.04 billion by 5.6%. Earnings per share came in at $1.57, surpassing the consensus estimate of $1.42 per share, according to Benzinga Pro data.

Apple shares jumped 1.5% to $210.62 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

  • Namib Minerals (NASDAQ:NAMM) shares gained 113.4% to $8.45 in pre-market trading.
  • 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) climbed 36.4% to $6.14 in pre-market trading after the company announced results from its 4D-150 SPECTRA clinical trial.
  • Erayak Power Solution Group Inc. (NASDAQ:RAYA) rose 31.4% to $0.0783 in pre-market trading. Erayak Power Solution Group shares fell 54% on Thursday after the company announced a $7 million registered direct offering.
  • Marwynn Holdings, Inc. (NASDAQ:MWYN) shares jumped 21.2% to $1.09 in pre-market trading after falling 8% on Thursday.
  • CCC Intelligent Solutions Holdings Inc. (NASDAQ:CCCS) surged 17.9% to $11.40 in pre-market trading after the company reported better-than-expected second-quarter financial results.
  • Reddit, Inc. (NYSE:RDDT) gained 15.4% to $185.95 in pre-market trading after the company reported better-than-expected second-quarter financial results and issued third-quarter sales guidance above estimates.
  • Figma, Inc. (NYSE:FIG) rose 13.4% to $133.30 in pre-market trading on momentum following Thursday’s IPO.
  • Cooper-Standard Holdings Inc. (NYSE:CPS) rose 12.4% to $27.16 in pre-market trading after the company reported better-than-expected quarterly financial results and issued FY25 sales guidance above estimates.
  • Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) gained 8.2% to $0.6508 in pre-market trading after dipping 23% on Thursday. Salarius Pharmaceuticals recently announced it has been granted a Nasdaq extension to regain compliance with its minimum bid price requirements.

Losers

  • Safe & Green Holdings Corp. (NASDAQ:SGBX) dipped 38.1% to $0.3600 in pre-market trading after falling 14% on Thursday.
  • Incannex Healthcare Inc. (NASDAQ:IXHL) declined 26.6% to $0.4300 in pre-market trading after dipping 34% on Thursday. The company reported Phase 2 results for IHL-42X.
  • Fluor Corporation (NYSE:FLR) fell 23.1% to $43.70 in pre-market trading after the company reported second-quarter results below estimates and lowered its FY25 adjusted EPS guidance.
  • VerifyMe, Inc. (NASDAQ:VRME) dipped 23% to $1.07 in pre-market trading. VerifyMe shares jumped over 102% on Thursday after the company announced it entered into a 3-year UPS Digital Channel Program Agreement with the United Parcel Service.
  • Smart Powerr Corp. (NASDAQ:CREG) fell 19.2% to $1.33 in pre-market trading after dipping over 12% on Thursday. Smart Powerr recently announced a 1-for-10 reverse split.
  • Enovix Corporation (NASDAQ:ENVX) declined 16.8% to $11.15 in pre-market trading after the company released its quarterly financial results.
  • Pop Culture Group Co., Ltd (NASDAQ:CPOP) shares tumbled 16.1% to $1.35 in pre-market trading after jumping 130% on Thursday.
  • Innodata Inc. (NASDAQ:INOD) fell 15.5% to $46.39 in pre-market trading following the release of its second-quarter financial results.
  • Bloom Energy Corporation (NYSE:BE) shares fell 15% to $31.82 in pre-market trading following the release of its quarterly financial results.
  • Coinbase Global, Inc (NASDAQ:COIN) fell 11.2% to $335.62 in pre-market trading after the company reported worse-than-expected quarterly adjusted EPS and sales.

Now Read This:

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.